Exploration of Tolerability and Dose Responses for a Yeast-based Probiotic
The purpose of this study is to evaluate the tolerability and efficacy of a yeast-based dietary supplement on gastrointestinal, mental, and skin health. Yeasts are naturally present on fruits and plants, and are used to bake bread, beer and wine. Some of these yeasts are commonly consumed and may actually benefit your gut health. The supplemental yeast could strengthen the gut lining or help good bacteria in the gut grow better.
In this study, the investigators will look at how two doses of a yeast-based supplement impacts gut health, bowel movement consistency, and mental health. The study will last 17 weeks and consist of 7 clinic visits (1 screening visit and 6 test visits).
研究概览
地位
详细说明
This study will take place at Colorado State University in Fort Collins, Colorado, USA. It will last approximately 17 weeks. This is a randomized, double-blind 3-arm crossover study with three treatments (placebo and two doses of Pichia kluyveri). The treatments will be taken for 4 weeks in a random order by every participant. Each treatment phase is separated by a 2-week washout. The first visit is a screening visit, where investigators will determine eligibility. Visit 2-7 are test visits where investigators will collect information on height, weight, waist, and hip measurements. Blood pressure will also be measured and the visit will conclude with a venous blood draw. During this visit, participants will also complete questionnaires about gut, mental, and skin health, menopause symptoms, and physical activity. A stool sample and bowel movement and diet records will be completed at home.
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Jenny Whittington, MS
- 电话号码:970-310-6843
- 邮箱:ijwhitt@rams.colostate.edu
研究联系人备份
- 姓名:Tiffany L Weir, PhD
- 电话号码:970-215-7571
- 邮箱:tiffany.weir@colostate.edu
学习地点
-
-
Colorado
-
Fort Collins、Colorado、美国、80521
- Colorado State University
-
首席研究员:
- Tiffany Weir, PhD
-
接触:
- Tiffany Weir, PhD
- 电话号码:970-215-7571
- 邮箱:tiffany.weir@colostate.edu
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- between 18-75 years old
- BMI <30 kg/m2
- mild/moderate gastrointestinal distress
Exclusion Criteria:
- Have taken antibiotics within two months of enrollment in the study
- Are currently taking statins, metformin, NSAIDs, and MAO inhibitors or other medications that could interfere with study outcomes, as determined by the study PI
- Have a current diagnosis of cancer, liver or kidney disease, gastrointestinal diseases (including Celiac, Crohn's, Ulcerative Colitis), and cardiometabolic disorders (cardiovascular disease, diabetes, etc.)
- Are pregnant or breastfeeding, or actively trying to lose weight
- Use excessive alcohol
- Use of supplements containing probiotics at any dose or if you are participating in other studies that may interfere with the bacteria in your gut.
- Unable or unwilling to consume capsules, provide stool or blood samples, track bowel movements and symptoms, and attend scheduled clinic visits.
- Have allergies to study treatments or medical supplies (eg. Latex, yeast, cellulose)
学习计划
研究是如何设计的?
设计细节
- 主要用途:支持治疗
- 分配:随机化
- 介入模型:交叉作业
- 屏蔽:双倍的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
安慰剂比较:安慰剂
|
Placebo - cellulose and hypromellose |
|
实验性的:Pichia kluyveri 9.9 x 10^7
|
9.9 x 10^7 Pichia kluyveri in microcrystalline cellulose and hypromellose |
|
实验性的:Pichia kluyveri 1 x 10^8
|
1 x 10^8 Pichia kluyveri in microcrystalline cellulose and hypromellose |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Severity of gastrointestinal symptoms using the Gastrointestinal Symptom Rating Scale (GSRS)
大体时间:4 weeks
|
The Gastrointestinal Symptom Rating Scale (GSRS) is a widely used tool for measuring gastrointestinal symptoms across five domains. The GSRS is scored between "No discomfort" and "Very severe discomfort" |
4 weeks
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Systemic inflammation indicated by circulating Tumor Necrosis Factor Alpha
大体时间:4 weeks
|
Tumor necrosis factor alpha, or TNF-a, is an inflammatory cytokine that is implicated in many diseases. |
4 weeks
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- 8533
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.